Pfizer in talks with India over expedited approval for COVID-19 vaccine

Reuters2021-05-03

NEW DELHI, May 3 (Reuters) - Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.

"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," he said.

"We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country."

(Reporting by Krishna N. Das; Editing by Tom Hogue)

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • MCYR
    2021-05-03
    MCYR
    its a mess in India
  • Nicolas_Lim_
    2021-05-03
    Nicolas_Lim_
    like n comment pls
    • MZ39
      sure! hope india's situation will improve, if not the whole world affected = another stock crash?
  • AppleMango
    2021-05-03
    AppleMango
    Is this the main reason why India is not able to get the vaccine?
  • Iinus
    2021-05-03
    Iinus
    Indian Govt dragging their feet 
    • mahi
      safety of population must be the top priority
    • mahi
      indeed
  • Milawow
    2021-05-03
    Milawow
    Pray for India
  • MKSoh
    2021-05-03
    MKSoh
    Too bad cannot help. More people dying.
发表看法
9